stockrow
Friday 6 November 2026
Export IMA’s income statement to Excel — free account
ImageneBio, Inc.
ImageneBio, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $800,000.00, down 77.1% from fiscal 2024.
- Revenue
- −60.1%
- EPS
- +85.9%
- Free cash flow
- +23.8%
Quarter to June 2026, against a year earlier
4.11
0.06
−1.44%
Follow IMA
Alert me
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
3 | 3 | 2 | 1 | 4 | — | — | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Altman Z-Score |
(1.12) | (23.54) | (0.07) | 0.24 | 5.12 | — | — | — | — |
P/S ratio |
5.47 | 3.20 | 9.06 | 6.07 | 11.32 | 9.62 | 9.62 | 9.62 | — |
Altman Z″-Score (non-manufacturers) |
5.55 | (55.36) | 6.17 | 4.56 | 8.16 | 1.04 | (1.22) | (30.11) | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
P/Operating CF |
(4.66) | (6.76) | (3.80) | (5.37) | (26.24) | (7.04) | (7.04) | (7.04) | — |
P/B ratio |
0.25 | 0.00 | 0.49 | 0.64 | 1.69 | 0.00 | 0.00 | 0.00 | — |
Price to Tangible BV |
0.25 | 0.00 | 0.49 | 0.64 | 1.69 | 0.00 | 0.00 | 0.00 | — |
EV/Sales |
(2.50) | 13.30 | (1.10) | 1.19 | 6.43 | 0.54 | 0.54 | 0.54 | — |
EV/EBITDA |
0.32 | 0.00 | 0.13 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
EV/Operating CF |
0.32 | (4.58) | 0.13 | (0.25) | (3.31) | (0.13) | (0.13) | (0.13) | — |
EV/FCF |
0.33 | (4.80) | 0.13 | (0.25) | (3.21) | (0.13) | (0.13) | (0.13) | — |
Quick Ratio |
12.05 | 0.70 | 12.35 | 7.30 | 8.54 | 5.74 | 3.38 | 4.75 | — |
Current Ratio |
12.49 | 0.72 | 12.58 | 7.44 | 8.70 | 5.86 | 3.51 | 5.22 | — |
Net Debt/EBITDA |
2.85 | 0.13 | 2.30 | 2.21 | 6.86 | 3.67 | 0.18 | (1.10) | — |
Debt/Assets |
0.00% | 47.10% | 0.00% | 1.11% | 0.75% | 0.11% | 91.73% | 302.65% | 0.00% |
Debt/Equity |
0.00 | (0.05) | 0.00 | 0.01 | 0.01 | 0.00 | (1.28) | (1.37) | — |
Asset Turnover |
0.01 | 0.03 | 0.05 | 0.07 | 0.15 | 0.07 | 0.26 | 0.10 | — |
Operating CF/Net income |
0.91 | 0.44 | 1.17 | 1.08 | 1.77 | 0.85 | (2.85) | 0.28 | — |
Capex/Depreciation |
0.00 | 0.64 | 0.41 | (1.79) | (3.24) | (2.55) | 0.00 | 0.00 | — |
| 225.87% | 989.95% | (43.04%) | (38.76%) | (63.87%) | 54.47% | 31.34% | 76.17% | — | |
| (62.04%) | (46.52%) | (37.42%) | (32.73%) | (16.39%) | (34.80%) | (31.54%) | (395.29%) | — | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Return on Tangible Assets |
(40.60%) | 1,166.44% | (40.87%) | (48.52%) | (16.11%) | (31.83%) | (27.27%) | (242.49%) | — |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Research and Development Expense of Revenue |
3,565.63% | 917.40% | 651.22% | 411.84% | 152.03% | 487.79% | 180.44% | 3,895.35% | — |
Selling, General and Administrative Expense of Revenue |
2,590.75% | 239.74% | 272.11% | 142.15% | 58.14% | 96.43% | 53.13% | 292.73% | — |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
1,923.88% | 151.29% | 83.32% | 48.18% | 16.71% | 19.55% | 0.00% | 0.00% | — |
Graham Net Nets |
3.58 | (6.98) | 1.88 | 1.42 | 0.56 | (1.17) | (1.17) | (1.17) | — |
Graham Number |
0.00 | 322.63 | 0.00 | 0.00 | 0.00 | 1,377.29 | 0.00 | 0.00 | — |
Earnings Yield |
(178.18%) | (156.33%) | (82.26%) | (72.93%) | (25.45%) | (50.04%) | (50.04%) | (50.04%) | — |
Free Cash Flow Yield |
(139.46%) | (86.59%) | (96.55%) | (79.70%) | (17.68%) | (43.64%) | (43.64%) | (43.64%) | — |
Revenue per Share |
0.16 | 2.93 | 2.63 | 5.18 | 13.29 | 39.92 | 0.38 | 0.03 | — |
Operating CF per Share |
(9.82) | (17.86) | (22.94) | (24.58) | (25.85) | (164.25) | 1.34 | (0.32) | — |
Capex per Share |
0.00 | 0.81 | (0.12) | (0.47) | (0.75) | (3.33) | 0.00 | 0.00 | — |
Free Cash Flow per Share |
(9.82) | (17.04) | (23.06) | (25.06) | (26.60) | (167.57) | 1.34 | (0.32) | — |
Cash per Share |
27.79 | 10.15 | 50.47 | 52.06 | 99.62 | 705.56 | 2.29 | 0.51 | — |
Shareholders Equity per Share |
27.33 | (134.48) | 48.83 | 48.75 | 89.18 | (438.77) | (1.71) | (1.28) | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
27.33 | (134.48) | 48.83 | 48.75 | 89.18 | (438.77) | (1.71) | (1.28) | — |
Free Cash Flow |
(47.84) | (20.35) | (80.16) | (75.54) | (62.01) | (38.59) | 47.93 | (11.61) | — |
Working Capital |
129.05 | (4.74) | 164.46 | 138.51 | 209.33 | 137.64 | 60.91 | 16.16 | — |
Capital Expenditures |
— | 0.97 | (0.41) | (1.43) | (1.76) | (0.77) | (0.32) | (0.30) | — |
Net Current Asset Value |
120.45 | (164.02) | 156.33 | 134.72 | 196.51 | (103.48) | (62.23) | (46.54) | — |
EV/EBIT |
0.32 | 0.00 | 0.13 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Capex to Sales |
0.00 | (0.28) | 0.05 | 0.09 | 0.06 | 0.08 | 0.00 | 0.00 | — |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Other line items | |||||||||
Depreciation/Fixed assets |
0.00 | 2.57 | (0.43) | 0.25 | 0.22 | 0.22 | 0.16 | 0.61 | — |
Cash ROIC |
(17.82%) | 14.44% | (23.22%) | (24.70%) | (14.03%) | (62.62%) | 48.17% | (33.27%) | — |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Inventory Turnover |
— | — | — | 0.00 | — | — | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Days of Inventory on Hand |
— | — | — | 0.00 | — | — | — | — | — |
Average Payables |
3.36 | 3.68 | 2.08 | 2.24 | 2.25 | 1.53 | 1.60 | 1.60 | — |
Average Assets |
84.45 | 104.01 | 182.18 | 210.07 | 208.14 | 127.19 | 53.33 | 10.34 | — |
Average Common Equity |
(23.20) | (4.89) | 158.36 | 177.42 | 53.41 | (81.26) | (53.65) | (53.65) | — |
Columns are period end dates · fundamentals updated 26 Oct 2026